Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

DSS Showcasing Game-Changing IT Solutions for Innovation and Mission Critical Information Systems at NVSBE 2023


“DSS and subsidiaries continually aim to be catalysts for advancing innovation and mission critical information systems for our federal customers,” said Mark Byers, president of DSS. “NVSBE provides the ideal opportunity for us to share our vision, solutions and services with Procurement Decision Makers (PDMs), VA leadership, and industry partners to help the VA reach its overall care mission for best meeting the needs of Veterans.”

DSS will be demonstrating its Comprehensive Care Coordination (C3) solution, which helps the VA reduce avoidable readmissions through real-time patient surveillance, alerting, documentation and reporting, along with its Patient Case Manager High Reliability Organization (PCM HRO) offering.

PCM HRO streamlines VA suicide prevention coordinator and case manager workflows, as well as automates the monitoring of Veterans at high risk for suicide. It is also designed to continuously monitor performance and achieve excellence, which is critical for the VA’s journey towards becoming a High Reliability Organization (HRO).

Serving as a signature event for the 10th year, NVSBE brings together more than 3,000 participants from the government, small and large businesses, and Veteran-focused associations and service organizations. As a key destination of NVSBE, the exhibit hall hosts more than 200 businesses to showcase their products and services to NVSBE registrants.

NVSBE is taking place on Nov. 7-9 at the Gaylord Palms Resort and Convention Center in Kissimmee, Fla.

About Document Storage Systems, Inc. (DSS)
Document Storage Systems, Inc. (DSS) is a catalyst for health care innovation, keeping pace with evolving technologies as a solutions provider, solutions integrator, and services contractor to the Department of Veterans Affairs. DSS is committed to assisting VA in its High Reliability Organization journey and delivering care quality for Veterans by meeting top initiatives, changing regulatory requirements, and implementing enhanced business transformation across VA enterprise. For more information, visit https://www.dssinc.com.

Media Contact

Matthew Langan, L&R Communications, 2022623340, matt@landrcomm.com

SOURCE Document Storage Systems, Inc. (DSS)

Intiveo Announces Global Insights, Providing Tailored Analytics to Dental Service Organizations


“We truly understand and recognize the unique challenges and complexities faced by DSOs and multi-location practices and are passionate about providing innovative and groundbreaking solutions to our customers,” said Josh deVries, co-founder and CEO of Intiveo. “With the launch of our new Global Insights, we are catering to the expansive and intricate dynamics of these dental operations to help them provide a consistent patient experience across all their practices, whether they have dozens or hundreds of locations.”

Global Insights seamlessly integrates with customers’ current Intiveo subscription, providing an enhanced analytics suite, other benefits include:

  • Comprehensive performance analytics: Access to a range of performance metrics and insights, offering a holistic view of operations across all locations.
  • Analytics-informed strategies: Dynamic dashboard widgets, in-depth reports, and granular insights put actionable data right at the fingertips of stakeholders.
  • Global access: Offers a single login to easily access practice data across multiple regions and groups.
  • Unified data aggregation: Capability to pull and synchronize data from various Practice Management Systems (PMS) databases, centralizing it into one accessible hub
  • Competitive Advantage: Through enhanced insights into confirmation rates and trends, optimize patient interactions and refine operational strategies, culminating in a superior patient experience.
  • Intuitive Interface: A user-friendly dashboard ensures that data, no matter how complex, is easily understandable and actionable for all team members.
  • Security and Reliability: Offers a highly secure, HIPAA-compliant platform.

Intiveo’s Global Insights is now available for all Intiveo customers. To learn more about Intiveo Global Insights visit intiveo.com/global-insights.

About Intiveo

Intiveo is a patient engagement software, designed to empower dental practices to enhance the patient experience. Our platform improves patient engagement and outcomes through two-way chat, recall reminders, quality improvement surveys, and online review management tools. With comprehensive integrations across major PMS systems, Intiveo streamlines front office workflows, centralizing patient engagement and communication management. Intiveo serves over 3,000 dental practices across North America, helping them improve their patients’ experience, streamline operations, and drive revenue growth while improving staff morale. For more information, please visit intiveo.com.

Media Contact

Shelby Busen, Talesplash for Intiveo, 1 (650)-769-4701, [email protected], https://intiveo.com/ 

SOURCE Intiveo

ClientSuccess Acquires Status to Merge the Worlds of Customer Success and Onboarding


“We’re thrilled to welcome Status to the ClientSuccess family,” said Dave Blake, Founder/CEO of ClientSuccess. “Teams are tired of dealing with the complexity and cost of using multiple solutions to deliver exceptional customer experiences. This strategic move aligns with our goal to provide both customer success and onboarding teams with specialized solutions for their needs while consolidating toolsets and eliminating operational silos. With the Status acquisition, we’ll deliver the best of both worlds—a tailored solution for onboarding teams, as well as the full power of ClientSuccess for teams who want both.”

Key Benefits of the Acquisition:

  • Customer Portal for Customer Collaboration: The enhanced customer portal offers real-time insights and transparency, allowing customers and success teams to align their goals and accelerate time-to-value.
  • Streamlined Execution and Alignment between Teams: The integration will ensure that both customer success and onboarding teams can communicate and execute plans seamlessly, cutting out the inefficiency of bouncing between multiple platforms.
  • Tool Consolidation: By offering a comprehensive suite that caters to both customer success and onboarding, the combined solutions will eliminate the need for multiple tools, driving much needed cost efficiencies.

Status’s modern approach to customer collaboration and project automation will be seamlessly integrated into ClientSuccess’s existing platform, enhancing its capabilities in the areas of onboarding, implementation and ongoing collaboration with customers throughout the customer lifecycle. Unifying customer onboarding and implementation tooling with the ClientSuccess offering brings new solutions to customer success teams, while empowering them to more fully engage with customers throughout important lifecycle events.

“We’re excited to join forces with ClientSuccess and leverage their experience and customer base to accelerate our growth and impact,” said Tanner Nordstrom, CEO of Status. “Our combined expertise will enable businesses to thrive in today’s competitive landscape by delivering world-class time-to-value and long-term customer retention and growth.”

For more information about ClientSuccess, Inc. and its customer success solutions, please visit www.clientsuccess.com. To learn more about Status and its customer experience analytics tools, please visit https://www.status.cx

Media Contact

Matthew Langie, ClientSuccess, 1 3852124878, [email protected], www.clientsuccess.com

SOURCE ClientSuccess

BiomEdit Awarded Grant to Develop Microbiome-Based Solution to Reduce Methane Emissions and Enhance Production Efficiency of Cattle in Africa and South Asia


BiomEdit’s solutions will target the rumen microbiome, which is the community of microorganisms that live in a cow’s digestive tract. The rumen microbiome plays a key role in digestion, with specific microorganisms responsible for methane production. The company will take a multi-pronged approach to leverage natural and synthetic probiotics and bioactives that robustly reduce methane emissions and increase cattle performance by inhibiting energy losses through methanogenesis and enhancing production of volatile fatty acids (VFA, the main source of energy from the rumen). Pathways to administer the innovations could take the form of feed additives, feed supplements, veterinary biologics, or pharmaceuticals.

“To make a meaningful impact on climate change, there must be a simultaneous benefit of reducing methane emission in cattle plus redirecting the spare energy, which would otherwise go to creating methane, to increasing feed efficiency so everyone can benefit from nutritious meat and milk – no matter where they are in the world. The answer is found through the microbiome and synthetic biology,” said Aaron Schacht, CEO of BiomEdit. “We are grateful for the Bill & Melinda Gates Foundation’s belief in our Methane Reduction R&D program, and excited to partner with them to enable both large- and small-scale producers to benefit from the innovations.”

A range of current strategies for methane reduction are in development or on the market, however, direct inhibition of methanogens has shown the largest effect on mitigating enteric methane emissions. An issue with many products currently available is farmers must fund an additional input to gain methane emission reduction and feed efficiency, so they do not often see a sufficient return on investment. Developing methane mitigation products that can improve production efficiency and pay for themselves will make this approach financially feasible for farmers, encouraging them to participate.

BiomEdit’s Development Platform and People

BiomEdit’s research is based on their unique platform combining well-curated microbial reference libraries, microbiome analytics, synthetic biology, and artificial intelligence (AI) to develop novel biologic products targeting significant challenges facing animals, humans, and our shared habitat.

As pioneers in the application of AI and machine learning in animal health, patterns and relationships are identified in the data to generate novel insights into how an animal’s microbiome shifts as it transitions from health to disease and back again – leading to a deeper level of knowledge about how the microbiome functions as an ecosystem.

The BiomEdit team is a diverse group of innovators with an entrepreneurial spirit: scientists with deep expertise in microbiome science and product development. The Methane Reduction R&D program team alone holds over 50 patent applications and more than 200 peer-reviewed scientific publications. The company also plans to collaborate with leading experts in rumen microbiome analysis at key academic research institutions on this project.

Keeping livestock producers’ livelihoods in mind, BiomEdit announced in October a first-of-its-kind collaboration with Athian, the world’s first cloud-based carbon marketplace for the livestock industry, to develop sustainability protocols and products in parallel. The company helps livestock producers capture and claim carbon credits earned through sustainability efforts by aggregating, validating, and certifying greenhouse gas (GHG) reductions, and monetizing those reductions for the producer through the sale of carbon insetting credits.

About BiomEdit

BiomEdit is an emerging animal health biotechnology company that leverages a unique platform combining the leading science of the microbiome with synthetic biology to innovate novel animal health products to address challenges in livestock production and pet health. Founded through a strategic partnership in 2022 between Elanco Animal Health (NYSE: ELAN) and Ginkgo Bioworks (NYSE: DNA), the company was born from a carve-out of technology and assets from Elanco combined with access to Ginkgo’s leading cell programming platform technology. BiomEdit is a private venture funded by Anterra Capital, Viking Global Investors, Ferment, and Nutreco Ventures. In 2022, BiomEdit was recognized by S&P Global Animal Health as Best Start-up in Animal Health in its annual animal health industry awards. www.biomedit.com

Media Contact

Julie Lawless, BiomEdit, 1 615-585-5861, [email protected], www.biomedit.com

SOURCE BiomEdit

Xtalks Announces its Life Science Webinar Calendar for November 2023


Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, clinical trials, commercialization & HEOR, drug discovery & development, food, fundamental research, healthcare, laboratory technology, medical device, patient recruitment & retention, pharmaceutical, pharma manufacturing & supply chain, pharmacovigilance and preclinical.

TORONTO, Nov. 1, 2023 /PRNewswire-PRWeb/ — Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field!

Visit http://www.xtalks.com to see our upcoming webinars:

BIOMARKERS
November 7– Spatial Protein and RNA Profiling: Seeing the Unseen in the Tumor Microenvironment
November 10– Leveraging Digital Biomarkers to Generate Real-World Physiological and Behavioral Data in CNS Clinical Studies

CLINICAL TRIALS
November 6– How to Prepare and Analyze your Lab Samples for Timely Clinical Decisions
November 6– FIH Trial Trends: How far we’ve come and where we’re going with PK data
November 9– Interactive Response Technology User Support: Where eClinical Software and a Site-Centric Mindset Converge
November 10– Unique Sourcing Solutions to Optimize Time and Budget in Clinical Trials
November 13– ICON’s World Children’s Day
November 15– Accelerating Vaccines to Clinical Trials — A Toolkit for Efficacy, Safety and Bioanalytical Studies
November 16– The Voice of the Hematological Malignancy Patient: Are You Listening?
November 27– Artificial Intelligence at ICON: How a world-leading healthcare intelligence CRO is transforming the delivery of clinical trials
November 27– Psychedelics in Focus: Clinical Trials, Transformations and Regulations
November 28– Clinical Trial Computerised Systems and Electronic Data – Lessons Learned Implementing the New EMA Guideline
November 28– Clario’s Oncology Webinar Series
November 28– Goal Attainment Scaling in Clinical Research and Practice: Insights from Experts
November 29– EU Clinical Trials Regulation and Clinical Trials Information System
November 29– Patient Centricity and Diversity: How to Design for Both in a World of Complex Clinical Trials

COMMERCIALIZATION & HEOR
November 7– Data Collection in Continued and Early Access Programs: Value and Utility vs. Challenges
November 20– Optimizing Trade Operations and Patient Management for Better Outcomes

DRUG DISCOVERY & DEVELOPMENT
November 1– AI and DNA-encoded libraries Synergy: Transforming Drug Discovery
November 8– Quantitative Bioanalysis of Antibody-Drug Conjugates by Mass Spectrometry
November 10– Accelerating Drug Discovery by Hypothesis and Synthesis Management Platform
November 13– Early-Stage Pharmaceutical Product Development to Reach the Clinic Faster
November 16– Antibody-Drug Conjugates: IP and R&D Trends to Inform Innovation
November 20– Vaccine Clinical Development: Key Ingredients to Improve Efficiency

FOOD
November 15– Formulating for Gut Health with Bio Hemp Fiber Crisps

FUNDAMENTAL RESEARCH
November 6– Life Science Regulatory Information Management Innovations in 2024
November 15– The Mind-bending Mushroom: Expanding Consciousness and Cultural Acceptance of Psychedelic Alkaloids as Medicinal Tools

HEALTHCARE
November 14– Technology-Enabled Solutions to Address Diabetes — The Largest Epidemic in Human History

LABORATORY TECHNOLOGY
November 2– Synthetic Co-Polymer Nanodisc Enabling Near-Native Membrane Protein Assays
November 3– Best Practices and Benefits of qPCR Automation
November 9– Quantifying Genetic Stability and Quality Control of Multiple Integrations of Orthogonal Transposases
November 10– Evolution of AI and Digitization in Precision Pathology and Image Analysis
November 17– Osmolality Analysis in Bioprocessing: From Theory to Practice

MEDICAL DEVICE
November 3– Medical Device Development and Market Strategy: Europe or US First? Or Both?

PATIENT RECRUITMENT & RETENTION
November 15– Patient Engagement in Clinical Trials: Beyond Recruitment to Long-Term Success

PHARMA MANUFACTURING & SUPPLY CHAIN
November 1– Building a Winning Life Science Eco-system – Leveraging the Quality Link between Platform, Processes and Patients
November 7– Busting 5 Digital Quality Management Myths
November 8– The Process of CDMO Selection for Antibody Development: Matching Capabilities to Need
November 21– Platform Manufacturing Processes for pDNA, mRNA, LNP and Fill/Finish in Clinical mRNA Therapies
November 22– Managing Multiple Complex Molecules in CDMO Projects

PHARMACEUTICAL
November 14– Optimizing Low GWP pMDI Sprays for Enhanced Performance & Sustainability
November 30– Facilitating Investment Decisions for Small to Midsize Pharmaceutical and Biotechnology Companies

PHARMACOVIGILANCE
November 30– Why outsourcing pharmacovigilance makes sense at an affiliate level

PRECLINICAL
November 2– EndoC-̒H5 Human Beta Cells in T1 and T2 Diabetes Models

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://www.xtalks.com.

Media Contact

Ayesha Rashid, Xtalks, +1 (416) 977-6555 x272, [email protected]

SOURCE Xtalks

Focused Approach Launches “Focused on Feeding” Program to Fill Critical Gap in Pediatric Feeding Therapy for Families, Professionals, and Clinics


“Feeding difficulties and inadequate nutrition in children not only impact their hunger and mood but also serve as a silent roadblock that affects their receptiveness to therapies like occupational therapy (OT) and speech therapy,” said Dena E. Kelly, LPC, BCBA, LBS, CEO and Founder of Focused Approach. “We’re dedicated to eliminating those obstacles and accelerating the overall success for children, their families, and their therapists.”

Unlike other approaches, which can actually heighten childrens’ anxieties, Focused on Feeding provides structure and introduces new foods that align with the child’s existing preferences. By slowly challenging them out of their comfort zone, using positive reinforcement strategies, and involving the entire family in a real-world environment, kids gain confidence to expand their diet.

“Focused Approach saved my 12-year old daughter’s life – taking her from hospitalization for malnutrition and requiring an NG tube to sustain her body, to over 2,000 calories per day orally in a matter of weeks,” said Carolyn Witrock. “Not only does our daughter no longer require a feeding tube, she is now eating a variety of foods and is thriving. We received care from one of the nation’s leading children’s hospitals, but it was Focused Approach that offered the program that changed our lives.”

Expanding upon its initial success treating children six months old through pre-teens since its founding in Summer 2023, Focused Approach is now offering its Focused on Feeding program to families and clinics nationwide.

The Focused on Feeding program seamlessly integrates into clinics already leveraging ABA principles to tackle a variety of skill-building and behavior challenges and can empower therapists to effectively address substantial feeding difficulties helping clients achieve faster results.

“Focused on Feeding is exactly what this field has been craving,” said Brittany Doan, MS, BCBA, LBA, LBS-PA. “Not only does this approach help families with some of the most challenging and complex feeding issues, it propels Board Certified Behavior Analysts (BCBA) to apply their ABA expertise to feeding. I look forward to seeing the positive changes it will bring to countless lives and look forward to the transformation it will inspire in the industry and beyond.”

Clinics interested in learning more about adding an effective feeding therapy program or families who would like to arrange an evaluation, please visit: www.focusedapproach.com

About Focused Approach

Focused Approach is a leading provider of specialized children’s services and programs, with an initial concentration on feeding therapy. Founded by a top authority in applied behavior analysis (ABA) and clinical psychology, Focused Approach’s Focused on Feeding program uses trusted, research-based techniques to address a wide scale of feeding challenges. Focused Approach delivers training and consultation to BCBA professionals, partners with existing clinics to add results-driven, full feeding programs into their offerings, and delivers direct feeding therapy support for families. Focused Approach goes above and beyond generalized services, tackling the most challenging and unique pediatric challenges. For more information, visit www.focusedapproach.com 

Media Contact

Alyson Kuritz, Focused Approach, 1 908.892.7149, [email protected], www.focusedapproach.com 

SOURCE Focused Approach

Accelerating Vaccines to Clinical Trials — A Toolkit for Efficacy, Safety and Bioanalytical Studies, Upcoming Webinar Hosted by Xtalks


Join this webinar to gain insights into the challenges and innovations in mRNA vaccines in clinical trials.

Join experts from Aragen Life Sciences, Dr. Narendra Deshmukh, Executive Director; and Dr. Kedar Purnapatre, Director, Bioanalytical & Bioassay, for the live webinar on Wednesday, November 15, 2023, at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Accelerating Vaccines to Clinical Trials — A Toolkit for Efficacy, Safety and Bioanalytical Studies.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, vkovacevic@xtalks.com

SOURCE Xtalks

Beyond Recruitment to Long-Term Success, Upcoming Webinar Hosted by Xtalks


The speakers will discuss:

  • Benefits of Holistic Patient Engagement: Our esteemed panelists will explore the manifold advantages of engaging patients throughout the clinical trial journey. From refining trial protocols to enhancing data quality and safety, we’ll explore how patient involvement can elevate your research
  • Recruiting and Retaining Diverse Populations: Achieving diversity in clinical trial participation is pivotal for generating representative data. Learn from experts about the strategies and best practices for recruiting and retaining diverse patient populations in trials
  • The Long-Term Commitment: Patient engagement doesn’t conclude with a single trial. Successful engagement requires a long-term commitment to building trust and relationships with patients. Discover why this investment is critical for sustained success in clinical research.
  • The Role of Technology: In today’s digital age, technology is pivotal in patient engagement. The panelists will explore how technology, including curated engagement content, ePRO/eCOA, telemedicine, wearables, BYOD (Bring Your Own Device), can drive meaningful interactions and motivate participants
  • Motivations and Rewards: Understand the psychology behind motivating patients to participate in trials actively. We’ll explore innovative incentive structures and reward systems that keep patients engaged, informed and eager to contribute to research

Don’t miss this opportunity to gain insights into the evolving landscape of patient engagement in clinical trials. Register now for an engaging discussion that will reshape the way you approach clinical research. Together, we can pave the way for more effective, inclusive and patient-centric clinical trials.

Join Kyle Hogan (moderator), President, Datacubed Health; Jackie Kent, Datacubed Health Board of Directors; Katherine Rizzi, User Experience Researcher, Roche; Danielle Horton, Associate Director, Tech & Innovation, Gilead; Brandy Starks, Patient Advocate & DEI Expert, DiversAlly Coaching, Consulting and Advisory Services; and Susan Stein, Patient Advocate, for the live webinar on Wednesday, November 15, 2023, at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Patient Engagement in Clinical Trials: Beyond Recruitment to Long-Term Success.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]

SOURCE Xtalks

Preferred Physical Therapy Expands Services with the Opening of Lenexa Clinic


PPT specializes in providing exceptional physical and occupational therapy through a combination of evidence-based practice, care excellence, and clinical excellence. Services offered by the MISH clinic will include occupational therapy, general physical therapy services, and pre/post-operative therapy.

“I am excited to be opening this new location in Lenexa and to be a part of the PPT team,” says Calderon. “This clinic is a great opportunity for us to meet the needs of our patients and offer excellent customer service/care to the Lenexa community. I look forward to helping our patients work to achieve their optimal level of function.”

For more information about the new MISH clinic and a full list of PPT’s services and offerings, please visit preferredptkc.com. To book an appointment with Mollie please call 913-218-1222.

About Preferred Physical Therapy
Preferred Physical Therapy (PPT) is a Kansas and Missouri-based, private physical therapy practice group. As a proud member of the Confluent Health family, PPT positively impacts patients’ lives by delivering the best care and results through proven research, innovative treatments and technologies, and an approach that treats patients like family. For more information, visit pptclinics.com, or find them on Facebook at @pptclinics.

Media Contact

Betsy Appleton, Confluent Health, 502-536-4584, [email protected], www.goconfluent.com

SOURCE Preferred Physical Therapy